MAPT and Alzheimer disease: Elevated levels of Tau protein could be an early manifestation of AD [1], which may have a negative impact on the patient's performance in post-operative neurological assessment tests, weakening or completely masking the associated positive change in symptomology in iNPH pathology after CSF diversion.